Vargas-Espinosa ML, Sanmartí-García G, Vázquez-Delgado E, Gay-Escoda C. Antiepileptic drugs for the treatment of neuropathic pain: A systematic review. Med Oral Patol Oral Cir Bucal. 2012 Sep 1;17 (5):e786-93.

doi:10.4317/medoral.18001

http://dx.doi.org/doi:10.4317/medoral.18001

1. Merskey H. Clarifying definition of neuropathic pain. Pain. 2002;96:408-9.
http://dx.doi.org/10.1016/S0304-3959(01)00423-7

2. Jensen TS. Anticonvulsivants in neuropathic pain: rationale and clinical evidence. Eur J Pain. 2002;6:61-8.
http://dx.doi.org/10.1053/eujp.2001.0324
PMid:11888243

3. Tremont-Lukats IW, Megeff C, Backjonga MM. Anticonvulsivants for neuropathic pain syndromes: mechanisms of action and place in therapy . Drugs. 2000;60:1029-52.
http://dx.doi.org/10.2165/00003495-200060050-00005
PMid:11129121

4. Koltzenburg M. Painful neuropathies. Curr Opin Neurol. 1998;11:515-21.
http://dx.doi.org/10.1097/00019052-199810000-00014
PMid:9848001

5. Jensen TS, Gottrup H, Kasch H, Nicolajsen L, Terkelsen AJ, Witting N. Has basic research contributed to chronic pain treatment? Acta Anaesthesiol Scand. 2001;45:1128-35.
http://dx.doi.org/10.1034/j.1399-6576.2001.450913.x
PMid:11683664

6. Ebell MH, Siwek J, Weiss BD, Woolf SH, Susman J, Ewigman B, et al. Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature. J Am Board Fam Pract. 2004;17:59-67.
http://dx.doi.org/10.3122/jabfm.17.1.59

7. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1-12.
http://dx.doi.org/10.1016/0197-2456(95)00134-4

8. Killian JM, Fromm GH. Carbazepine in the treatment of neuralgia. Use of side effects. Arch Neurol. 1968;19:129-36.
http://dx.doi.org/10.1001/archneur.1968.00480020015001
PMid:4877400

9. Nicol CF. A four year double-blind study of tegretol in facial pain. Headache. 1969;9:54-7.
http://dx.doi.org/10.1111/j.1526-4610.1969.hed0901054.x

10. Campbell FG, Graham JG, Zilkha KJ. Clinical trial of carbazepine (tegretol) in trigeminal neuralgia. J Neurol Neurosurg Psychiatry. 1966;29:265-7.
http://dx.doi.org/10.1136/jnnp.29.3.265
PMid:50411

11. Sturman RH, O’Brien FH. Non-surgical treatment of tic douloureux with carbamazepine (G32883). Headache. 1969;9:88-91.
http://dx.doi.org/10.1111/j.1526-4610.1969.hed0901088.x

12. Rockliff BW, Davis EH. Controlled sequential trials of carbamazepine in trigeminal neuralgia. Arch Neurol. 1966;15:129-36.
http://dx.doi.org/10.1001/archneur.1966.00470140019003
PMid:5329617

13. Lechin F, van der Dijs B, Lechin ME, Amat J, Lechin AE, Cabrera A, et al. Pimozide therapy for trigeminal neuralgia. Arch Neurol. 1989;46:960-3.
http://dx.doi.org/10.1001/archneur.1989.00520450030015
PMid:2673161

14. Lindström P, Lindblom U. The analgesic effect of tocainide in trigeminal neuralgia. Pain. 1987;28:45-50.
http://dx.doi.org/10.1016/0304-3959(87)91058-X

15. Vilming ST, Lyberg T, Lataste X. Tizanidine in the management of trigeminal neuralgia. Cephalalgia. 1986;6:181-2.
http://dx.doi.org/10.1046/j.1468-2982.1986.0603181.x
PMid:3533272

16. Wiffen PJ, McQuay HJ, Moore RA. Carbamazepine for acute and chronic pain. Cochrane Database Syst Rev. 2005;3:CD005451.
PMid:16034977

17. Jorns TP, Zakrzewska JM. Evidence-based approach to the medical management of trigeminal neuralgia. Br J Neurosurg. 2007;21:253-61.
http://dx.doi.org/10.1080/02688690701219175
PMid:17612914

18. Dworkin RH, Corbin AE, Young JP Jr, Sharma U, LaMoreaux L, Bockbrader H, et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology. 2003;60:1274-83.
http://dx.doi.org/10.1212/01.WNL.0000055433.55136.55
PMid:12707429

19. Freynhagen R, Strojek K, Griesing T, Whalen E, Balkenohl M. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomized, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain. 2005;115:254-63.
http://dx.doi.org/10.1016/j.pain.2005.02.032
PMid:15911152

20. Sabatowski R, Gálvez R, Cherry DA, Jacquot F, Vicent E, Maisonobe P, et al. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain. 2004;109:26-35.
http://dx.doi.org/10.1016/j.pain.2004.01.001
PMid:15082123

21. Stacey BR, Barrett JA, Whalen E, Phillips KF, Rowbotham MC. Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief. J Pain. 2008;9:1006-17.
http://dx.doi.org/10.1016/j.jpain.2008.05.014
PMid:18640074

22. van Seventer R, Feister HA, Young JP Jr, Stoker M, Versavel M, Rigaudy L. Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: A 13-week, randomized trial. Curr Med Res Opin. 2006;22:375-84.
http://dx.doi.org/10.1185/030079906X80404
PMid:16466610

23. Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev. 2009;3:CD007076.
PMid:19588419

24. Rice AS, Maton S; Postherpetic Neuralgia Study Group. Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain. 2001;94:215-24.
http://dx.doi.org/10.1016/S0304-3959(01)00407-9

25. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA. 1998;280:1837-42.
http://dx.doi.org/10.1001/jama.280.21.1837

26. Wiffen PJ, McQuay HJ, Edwards JE, Moore RA. Gabapentin for acute and chronic pain. Cochrane Database Syst Rev. 2005;3:CD005452.
PMid:16034978

27. Mellegers MA, Furlan AD, Mailis A. Gabapentin for neuropathic pain: systematic review of controlled and uncontrolled literature. Clin J Pain. 2001;17:284-95.
http://dx.doi.org/10.1097/00002508-200112000-00002
PMid:11783808

28. Parsons B, Tive L, Huang S. Gabapentin: a pooled analysis of adverse events from three clinical trials in patients with postherpetic neuralgia. Am J Geriatr Pharmacother. 2004;2:157-62.
http://dx.doi.org/10.1016/j.amjopharm.2004.09.004
PMid:15561647

29. Plaghki L, Adriaensen H, Morlion B, Lossignol D, Devulder J. Systematic overview of the pharmacological management of postherpetic neuralgia. An evaluation of the clinical value of critically selected drug treatments based on efficacy and safety outcomes from randomized controlled studies. Dermatology. 2004;208:206-16.
http://dx.doi.org/10.1159/000077301
PMid:15118369

30. Rosenberg JM, Harrell C, Ristic H, Werner RA, de Rosayro AM. The effect of gabapentin on neuropathic pain. Clin J Pain. 1997;13:251-5.
http://dx.doi.org/10.1097/00002508-199709000-00011
PMid:9303258

31. Kochar DK, Garg P, Bumb RA, Kochar SK, Mehta RD, Beniwal R, et al. Divalproex sodium in the management of post-herpetic neuralgia: a randomized double-blind placebo-controlled study. QJM. 2005;98:29-34.
http://dx.doi.org/10.1093/qjmed/hci005
PMid:15625351

32. Gremeau-Richard C, Woda A, Navez ML, Attal N, Bouhassira D, Gagnieu MC, et al. Topical clonazepam in stomatodynia: A randomised placebo-controlled study. Pain. 2004;108:51-7.
http://dx.doi.org/10.1016/j.pain.2003.12.002
PMid:15109507